Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007-2011

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Suess, Thorsten ^a   Remschmidt, Cornelius ^a   Schink, Susanne B ^a   Schweiger, Brunhilde ^a   Heider, Alla ^a   Milde, Jeanette ^a   Nitsche, Andreas ^a   Schroeder, Kati ^a   Doellinger, Joerg ^a   Braun, Christian ^a   Haas, Walter ^a   Krause, Gérard ^a   Buchholz, Udo ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLU LIKE SYNDROME; GERMANY; HUMAN; HUMAN TISSUE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SCORING SYSTEM; SEASONAL INFLUENZA; VIRUS CULTURE; VIRUS LOAD; VIRUS SHEDDING;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; GERMANY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; VIRAL LOAD; VIRUS SHEDDING;

ORTHOMYXOVIRIDAE;

EID: 84871121907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051653     Document Type: Article

References (36)

1. An der Heiden M, Buchholz U, Krause G, Kirchner G, Claus H, et al. (2009) Breaking the waves: modelling the potential impact of public health measures to defer the epidemic peak of novel influenza A/H1N1. PLoS ONE 4: e8356.
2. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209-214.
3. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, et al. (2006) Strategies for mitigating an influenza pandemic. Nature 442: 448-452.
4. Liao CM, Yang SC, Chio CP, Chen SC, (2010) Understanding influenza virus-specific epidemiological properties by analysis of experimental human infections. Epidemiol Infect 138: 825-835.
5. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785.
6. Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, et al. (2010) Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 362: 2175-2184.
7. Loeb M, Singh PK, Fox J, Russell ML, Pabbaraju K, et al. (2012) Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities. J Infect Dis.
8. Suess T, Remschmidt C, Schink SB, Schweiger B, Nitsche A, et al. (2012) The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011. BMC Infect Dis 12: 26.
9. Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, et al. (2000) Oral oseltamivir in human experimental influenza B infection. Antivir Ther 5: 205-213.
10. Suess T, Buchholz U, Dupke S, Grunow R, an der Heiden M, et al. (2010) Shedding and transmission of novel influenza virus A/H1N1 infection in households-Germany, 2009. Am J Epidemiol 171: 1157-1164.
11. Schulze M, Nitsche A, Schweiger B, Biere B, (2010) Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One 5: e9966.
12. Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, et al. (2010) Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 51: 1033-1041.
13. Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, et al. (2010) Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 201: 1509-1516.
14. Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, et al. (2011) Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci U S A 108: 2825-2830.
15. Boelle PY, Ansart S, Cori A, Valleron AJ, (2011) Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respi Viruses 5: 306-316.
16. Cowling BJ, Fang VJ, Riley S, Malik Peiris JS, Leung GM, (2009) Estimation of the serial interval of influenza. Epidemiology 20: 344-347.
17. Viboud C, Boelle PY, Cauchemez S, Lavenu A, Valleron AJ, et al. (2004) Risk factors of influenza transmission in households. Br J Gen Pract 54: 684-689.
18. Cowling BJ, Chan KH, Fang VJ, Cheng CK, Fung RO, et al. (2009) Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 151: 437-446.
19. Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, et al. (1999) Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 58: 420-425.
20. Mori I, Nagafuji H, Matsumoto K, Kimura Y, (1997) Use of the polymerase chain reaction for demonstration of influenza virus dissemination in children. Clin Infect Dis 24: 736-737.
21. Khakpour M, Saidi A, Naficy K, (1969) Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. Br Med J 4: 208-209.
22. Tse H, To KK, Wen X, Chen H, Chan KH, et al. (2011) Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One 6: e22534.
23. Chan MC, Lee N, Chan PK, Leung TF, Sung JJ, (2009) Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms. J Clin Virol 45: 208-211.
24. Suryaprasad A, Morgan OW, Peebles P, Warner A, Kerin TK, et al. (2011) Virus detection and duration of illness among patients with 2009 pandemic influenza A (H1N1) virus infection in Texas. Clin Infect Dis 52Suppl 1: S109-115.
25. To KK, Chan KH, Li IW, Tsang TY, Tse H, et al. (2010) Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 82: 1-7.
26. Gu Y, Komiya N, Kamiya H, Yasui Y, Taniguchi K, et al. (2011) Pandemic (H1N1) 2009 transmission during presymptomatic phase, Japan. Emerg Infect Dis 17: 1737-1739.
27. Donnelly CA, Finelli L, Cauchemez S, Olsen SJ, Doshi S, et al. (2011) Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations. Clin Infect Dis 52Suppl 1: S123-130.
28. Bhattarai A, Villanueva J, Palekar RS, Fagan R, Sessions W, et al. (2011) Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak-Pennsylvania, May-June 2009. Clin Infect Dis 52Suppl 1: S102-108.
29. Killingley B, Greatorex J, Cauchemez S, Enstone JE, Curran M, et al. (2010) Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. Health Technol Assess 14: 237-354.
30. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, et al. (2010) Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 50: 707-714.
31. Li CC, Wang L, Eng HL, You HL, Chang LS, et al. (2010) Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 16: 1265-1272.
32. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, et al. (1999) Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. Jama 282: 1240-1246.
33. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, et al. (2000) Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 355: 1845-1850.
34. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, et al. (2000) Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. Jama 283: 1016-1024.
35. Couch RB, Douglas RG Jr, Fedson DS, Kasel JA, (1971) Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis 124: 473-480.
36. Cheng CK, Cowling BJ, Chan KH, Fang VJ, Seto WH, et al. (2009) Factors affecting QuickVue Influenza A+B rapid test performance in the community setting. Diagn Microbiol Infect Dis 65: 35-41.